Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03441048 · COMPLETED
Trial details
- NCT number
- NCT03441048
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-22
- Primary completion
- 2024-05-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.